Abstract

SARS-CoV2 is a novel respiratory viral illness responsible for a global pandemic that started in the late 2019. Signs and symptoms being non-specific, clinicians relied on a constellation of abnormal results obtained from clinical investigations and imaging to diagnose the illness prior to the availability of widespread, timely testing. One proposed metric was the increased neutrophil to lymphocyte ratio (NLR) observed in patients suffering from COVID-19. Those with higher ratios were generally admitted to the Intensive Care Unit (ICU) with detrimental outcomes. Neutrophilia and lymphocytopenia were common occurrences in COVID-19 cases worldwide, even among those not severe enough to be in ICU. Here, we present a case of a 41-year-old SARS-CoV2 positive male who initially presented with fever, but then developed neutropenia. It is unknown whether his decreased neutrophil count was attributable current medications, an additional underlying infection, or whether it was due to the virus itself. Review of the literature did not yield any similar cases. Learning Points Prior clinical cases have shown that COVID positive patients present with an increased neutrophil to lymphocyte ratio (NLR) where a higher NLR correlates to increased clinical severity; however, our case highlights a case of neutropenia in a covid-19 patient.

Highlights

  • SARS CoV-2 associated disease COVID-19 was first reported in Wuhan, China in 2019 [1]

  • Learning Points Prior clinical cases have shown that COVID positive patients present with an increased neutrophil to lymphocyte ratio (NLR) where a higher NLR correlates to increased clinical severity; our case highlights a case of neutropenia in a covid-19 patient

  • Prior clinical cases have shown that COVID positive patients present with an increased neutrophil to lymphocyte ratio (NLR) where a higher NLR correlates to increased clinical severity, our case provides evidence to suggest neutropenia as a possible complication [6]

Read more

Summary

A Case of Neutropenia Associated with COVID-19

Sherif Elkattawy1* Sarah Ayad, Neil Williams, Archanna Radakrishnan, Justin Joy, Omar Elkattawy, Kirolos Gergis, Steven J Narbut1 1Rutgers-New Jersey Medical School/Trinitas, Elizabeth, NJ, USA 2Saint George’s Medical School, Grenada, West Indies 3Rutgers-New Jersey Medical School, Newark, NJ, USA 4McLaren Health Care, Flint, MI, USA. J Health Care and Research. 2021 Jul 19;2(2):133

Introduction
Discussion
Conclusions
Funding None

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.